Literature DB >> 10228019

Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7.

M Yasukawa1, A Hasegawa, I Sakai, H Ohminami, J Arai, S Kaneko, Y Yakushijin, K Maeyama, H Nakashima, R Arakaki, S Fujita.   

Abstract

Recent studies have demonstrated that human herpesvirus 6 (HHV-6) and HHV-7 interact with HIV-1 and alter the expression of various surface molecules and functions of T lymphocytes. The present study was undertaken to clarify whether coreceptors for HIV-1, CXCR4 and CCR5, are necessary for HHV-6 and HHV-7 infection. Although CXCR4 and CCR5 appeared not to be the coreceptors for these viruses, marked down-regulation of CXCR4, but not CCR5, was detected in HHV-6 variant A (HHV-6A)-, HHV-6 variant B (HHV-6B)-, and HHV-7-infected cells. Down-regulation of CXCR4 resulted in impairment of chemotaxis and a decreased level of elevation of the intracellular Ca2+ concentration in response to stromal cell-derived factor-1. Northern blot analysis of mRNAs extracted from HHV-6A-, HHV-6B-, and HHV-7-infected CD4+ T lymphocytes demonstrated a markedly decreased level of CXCR4 gene transcription, but the posttranscriptional stability of CXCR4 mRNA was not significantly altered. These data demonstrate that unlike HIV-1, HHV-6 and HHV-7 infections do not require expression of CXCR4 or CCR5, whereas marked down-regulation of CXCR4 is induced by these viruses, suggesting that HHV-6 and HHV-7 infections may render CD4+ T lymphocytes resistant to T lymphocyte-tropic HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10228019

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

2.  EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.

Authors:  Adrienne Chen; Bo Zhao; Elliott Kieff; Jon C Aster; Fred Wang
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  CXC-chemokine receptor 4 is not a coreceptor for human herpesvirus 7 entry into CD4(+) T cells.

Authors:  Y Zhang; S Hatse; E De Clercq; D Schols
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 4.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 5.  CXCR4: a virus's best friend?

Authors:  Kathleen L Arnolds; Juliet V Spencer
Journal:  Infect Genet Evol       Date:  2014-05-02       Impact factor: 3.342

6.  CXCR4 is down-regulated in cells infected with the CD4-independent X4 human immunodeficiency virus type 1 isolate m7NDK.

Authors:  S T Valente; C Chanel; J Dumonceaux; R Olivier; S Marullo; P Briand; U Hazan
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Human B cells immortalized with Epstein-Barr virus upregulate CCR6 and CCR10 and downregulate CXCR4 and CXCR5.

Authors:  Takashi Nakayama; Ryuichi Fujisawa; Dai Izawa; Kunio Hieshima; Kenzo Takada; Osamu Yoshie
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.

Authors:  Miki Kakimoto; Atsuhiko Hasegawa; Shigeru Fujita; Masaki Yasukawa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Human herpesvirus 6 infection impairs Toll-like receptor signaling.

Authors:  Yuichi Murakami; Kazushi Tanimoto; Hiroshi Fujiwara; Jun An; Koichiro Suemori; Toshiki Ochi; Hitoshi Hasegawa; Masaki Yasukawa
Journal:  Virol J       Date:  2010-05-10       Impact factor: 4.099

10.  Persistent infection with primate foamy virus type 1 increases human immunodeficiency virus type 1 cell binding via a Bet-independent mechanism.

Authors:  Cecile Schiffer; Charles-Henri Lecellier; Abdelkrim Mannioui; Nathalie Felix; Elisabeth Nelson; Jacqueline Lehmann-Che; Marie-Louise Giron; Jean Claude Gluckman; Ali Saib; Bruno Canque
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.